Consequently, in metastatic IBC, which may be considered later stage disease in which the tumor seems to have evaded the immune response, there was a borderline significant association with increased TAMs ( Fig.
← all excerpts
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant.
1
—
—